Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Intangibles (2016 - 2025)

Lisata Therapeutics' Intangibles history spans 11 years, with the latest figure at $139000.0 for Q3 2025.

  • For Q3 2025, Intangibles fell 33.81% year-over-year to $139000.0; the TTM value through Sep 2025 reached $139000.0, down 33.81%, while the annual FY2024 figure was $192000.0, 27.0% down from the prior year.
  • Intangibles reached $139000.0 in Q3 2025 per LSTA's latest filing, down from $157000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $317000.0 in Q1 2023 to a low of $139000.0 in Q3 2025.
  • Average Intangibles over 3 years is $227727.3, with a median of $228000.0 recorded in 2024.
  • Peak YoY movement for Intangibles: dropped 22.71% in 2024, then plummeted 33.81% in 2025.
  • A 3-year view of Intangibles shows it stood at $263000.0 in 2023, then decreased by 27.0% to $192000.0 in 2024, then dropped by 27.6% to $139000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Intangibles are $139000.0 (Q3 2025), $157000.0 (Q2 2025), and $174000.0 (Q1 2025).